Anhui Huangshan Capsule Co Ltd (002817) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.046x

Based on the latest financial reports, Anhui Huangshan Capsule Co Ltd (002817) has a cash flow conversion efficiency ratio of 0.046x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.15 Million ≈ $6.61 Million USD) by net assets (CN¥973.03 Million ≈ $142.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002817 equity to assets ratio to measure how much of total assets are equity-financed.

Anhui Huangshan Capsule Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Anhui Huangshan Capsule Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Anhui Huangshan Capsule Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Anhui Huangshan Capsule Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Huangshan Capsule Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zona Franca de Iquique S.A
SN:ZOFRI
0.072x
Launch One Acquisition Corp. Unit
NASDAQ:LPAAU
0.000x
Launch Two Acquisition Corp. Class A Ordinary Shares
NASDAQ:LPBB
-0.001x
Strike Energy Ltd
AU:STX
0.079x
Thoresen Thai Agencies Public Company Limited
BK:TTA-R
0.014x
Formosan Rubber Group Inc
TW:2107
0.014x
IAR Systems Group AB (publ)
ST:IAR-B
0.096x
Al Aqar Healthcare Reit
KLSE:5116
0.102x

Annual Cash Flow Conversion Efficiency for Anhui Huangshan Capsule Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Huangshan Capsule Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 002817 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥973.03 Million
≈ $142.38 Million
CN¥107.44 Million
≈ $15.72 Million
0.110x +59.56%
2024-12-31 CN¥917.76 Million
≈ $134.30 Million
CN¥63.51 Million
≈ $9.29 Million
0.069x -37.55%
2023-12-31 CN¥901.11 Million
≈ $131.86 Million
CN¥99.86 Million
≈ $14.61 Million
0.111x +14.02%
2022-12-31 CN¥854.21 Million
≈ $125.00 Million
CN¥83.02 Million
≈ $12.15 Million
0.097x -8.56%
2021-12-31 CN¥809.98 Million
≈ $118.52 Million
CN¥86.09 Million
≈ $12.60 Million
0.106x +29.68%
2020-12-31 CN¥765.15 Million
≈ $111.97 Million
CN¥62.71 Million
≈ $9.18 Million
0.082x +14.42%
2019-12-31 CN¥726.33 Million
≈ $106.28 Million
CN¥52.03 Million
≈ $7.61 Million
0.072x +81.29%
2018-12-31 CN¥696.59 Million
≈ $101.93 Million
CN¥27.52 Million
≈ $4.03 Million
0.040x -40.75%
2017-12-31 CN¥666.10 Million
≈ $97.47 Million
CN¥44.42 Million
≈ $6.50 Million
0.067x +29.37%
2016-12-31 CN¥630.95 Million
≈ $92.33 Million
CN¥32.53 Million
≈ $4.76 Million
0.052x -58.59%
2015-12-31 CN¥323.92 Million
≈ $47.40 Million
CN¥40.32 Million
≈ $5.90 Million
0.124x -33.35%
2014-12-31 CN¥278.78 Million
≈ $40.79 Million
CN¥52.07 Million
≈ $7.62 Million
0.187x +91.21%
2013-12-31 CN¥236.77 Million
≈ $34.65 Million
CN¥23.13 Million
≈ $3.38 Million
0.098x -70.66%
2012-12-31 CN¥197.36 Million
≈ $28.88 Million
CN¥65.70 Million
≈ $9.61 Million
0.333x +116.86%
2011-12-31 CN¥149.43 Million
≈ $21.87 Million
CN¥22.94 Million
≈ $3.36 Million
0.153x --

About Anhui Huangshan Capsule Co Ltd

SHE:002817 China Drug Manufacturers - Specialty & Generic
Market Cap
$246.85 Million
CN¥1.69 Billion CNY
Market Cap Rank
#15601 Global
#4463 in China
Share Price
CN¥5.64
Change (1 day)
-1.57%
52-Week Range
CN¥5.64 - CN¥8.54
All Time High
CN¥62.96
About

Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl st… Read more